慢性己酮可可碱治疗对间歇性跛行患者运动耐力和血流动力学参数的影响（作者译）
[The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
作者信息
Rudofsky G, Brock F E, Ulrich M, Nobbe F
出版信息
Med Klin. 1979 Jul 13;74(28-29):1093-6.
PMID:556192
Abstract
In an open clinical trial 14 patients with intermittent claudication caused by an obliteration of the femoral artery received 400 mg pentoxifylline 3 times daily over a period of 6 months. The walking distance, time to peak flow and calf ergometry showed a significant increase. Minor improvement of working hyperemia and peak flow could be found. The systolic pressure gradient over the obstruction didn't change. No patient complained about side effects.
摘要
在一项开放性临床试验中，14例因股动脉闭塞导致间歇性跛行的患者，在6个月的时间里每日3次接受400毫克己酮可可碱治疗。步行距离、达到峰值血流的时间和小腿测力计检查结果显示有显著增加。工作性充血和峰值血流有轻微改善。阻塞部位的收缩压梯度没有变化。没有患者抱怨有副作用。
相似文献
1
2
Pentoxifylline--a new drug for the treatment of intermittent claudication.
Indian Heart J. 1989 Mar-Apr;41(2):127-33.
3
4
Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.监督下运动及气动足部和小腿加压对股浅动脉闭塞所致间歇性跛行患者步行能力的改善：一项随机对照试验
Eur J Vasc Endovasc Surg. 2005 Aug;30(2):164-75. doi: 10.1016/j.ejvs.2005.03.011.
5
Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.醋硝香豆素与己酮可可碱治疗间歇性跛行：一项对照临床研究。APIC研究小组
Angiology. 1989 Apr;40(4 Pt 1):237-48.
6
Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Angiology. 1989 Sep;40(9):795-802. doi: 10.1177/000331978904000904.
7
8
[Training by walking and drug therapy of peripheral arterial occlusive disease].
Vasa Suppl. 1987;20:384-7.
9
[Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
MMW Munch Med Wochenschr. 1977 Jul 1;119(26):901-4.
10
Zotero 插件